Our portfolio companies

Portfolio Our portfolio companies



A new approach to calcification disorders.

Sanifit is a clinical stage company that develops SNF472 a compound for the treatment of End Stage Renal Disease (ESRD) and calciphylaxis patients undergoing haemodialysis and suffer from severe cardiovascular complications related to calcification of their blood vessels.

  • Industry Biotech